Healthy Subjects
Showing 26 - 50 of 775
Healthy Subjects Trial in Madrid (Morton extension)
Completed
- Healthy Subjects
- Morton extension
-
Madrid, SpainEva María Martínez-Jimenez
Jun 2, 2023
Healthy Subjects, Pharmacokinetics of 14C-labeled of LXI-15028 Trial in Suzhou ([14C]LXI-15028)
Completed
- Healthy Subjects
- Pharmacokinetics of 14C-labeled of LXI-15028
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
May 22, 2023
Healthy Subjects Trial in Cheongju-si (DW6013)
Completed
- Healthy Subjects
-
Cheongju-si, Korea, Republic ofChungbuk National University Hospital
May 16, 2023
Healthy Subjects Trial in Cheongju-si (DW6013)
Completed
- Healthy Subjects
-
Cheongju-si, Korea, Republic ofChungbuk National University Hospital
May 16, 2023
Healthy Subjects Trial in Austin (Vorasidenib 40 mg Oral Tablet, Ciprofloxacin 500 mg Oral Tablet, Vorasidenib 10 mg Oral
Recruiting
- Healthy Subjects
- Vorasidenib 40 mg Oral Tablet
- +2 more
-
Austin, TexasPPD Development
May 3, 2023
Healthy Subjects, Diet Intervention Trial in Lund (Non-polar lipids, No lipids, Polar lipids low)
Recruiting
- Healthy Subjects
- Diet Intervention
- Non-polar lipids
- +3 more
-
Lund, Välj..., SwedenThe Human Trial Facility, Food Technology, Engineering and Nutri
May 4, 2023
Healthy Subjects Trial in Cheongju-si (DW6014)
Completed
- Healthy Subjects
-
Cheongju-si, Korea, Republic ofChungbuk National University Hospital
Apr 10, 2023
Healthy Subjects, Diet, Healthy Trial in Lund (Bread products)
Not yet recruiting
- Healthy Subjects
- Diet, Healthy
- Bread products
-
Lund, Välj..., SwedenLund University, dep of Food Technology, Engineering, and Nutrit
Apr 19, 2023
Healthy Subjects Trial (Mucointegration)
Not yet recruiting
- Healthy Subjects
- Mucointegration
- (no location specified)
Apr 7, 2023
Healthy Subjects Trial in Suzhou ([14C]JT001)
Recruiting
- Healthy Subjects
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Apr 4, 2023
Healthy Subjects Trial in Shanghai (TPN171H 10 mg Group, TPN171H 30 mg Group, TPN171H 40 mg Group)
Recruiting
- Healthy Subjects
- TPN171H 10 mg Group
- +3 more
-
Shanghai, Shanghai, ChinaHuashan Hospital affiliated to Fudan University
Feb 19, 2023
Cardiac Output Measurements, Healthy Subjects Trial in Leuven (Pulsify sensor, State-of-the-art ultrasound equipment)
Completed
- Cardiac Output Measurements
- Healthy Subjects
- Pulsify sensor
- State-of-the-art ultrasound equipment
-
Leuven, Vlaams-Brabant, BelgiumUZ Leuven
Feb 8, 2023
Healthy Subjects Trial in Chang chun (Vicagrel and omeprazole)
Recruiting
- Healthy Subjects
- Vicagrel and omeprazole
-
Chang chun, Jilin, ChinaPhase I Clinical Research Center of The First Hospital of Jilin
Jan 29, 2023
Different Ankle Positions on Nerve Conduction Parameters of Deep
Completed
- Healthy Subjects
-
Aga, EgyptMahmoud Salah
Jan 27, 2023
Next Generation CT Reconstruction (NextGenIR)
Recruiting
- Healthy Subjects
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Studies of Frontal Lobe Brain Functioning in Schizophrenia
Completed
- Healthy Subjects
- +2 more
- Oxygen-15 Water
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Healthy Subjects Trial in Suzhou (Itraconazole, IBI351, Dextromethorphan)
Not yet recruiting
- Healthy Subjects
- Itraconazole
- +2 more
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Suzhou University
Jan 25, 2023
Healthy Subjects Trial in Lenexa (DZD9008 and intraconazole, DZD9008 and carbamazepine)
Active, not recruiting
- Healthy Subjects
- DZD9008 and intraconazole
- DZD9008 and carbamazepine
-
Lenexa, KansasPharmaceutical Research Associates, Inc.
Jan 18, 2023
Healthy Subjects Trial in Suzhou (IBI351, Esomeprazole)
Not yet recruiting
- Healthy Subjects
-
Suzhou, Jiangsu, Chinathe First Affiliated Hospital of Suzhou University
Jan 13, 2023
Healthy Subjects Trial in Charlottesville (Ultrasound stimulation intensity, Ultrasound stimulation site)
Recruiting
- Healthy Subjects
- Ultrasound stimulation intensity
- Ultrasound stimulation site
-
Charlottesville, VirginiaUniversity of Virginia, Division of Nephrology; Center for Immun
Jan 6, 2023
Healthy Subjects Trial in Nottingham (Quizartinib diHCl, 14C-Quizartinib solution for infusion)
Completed
- Healthy Subjects
- Quizartinib dihydrochloride
- 14C-Quizartinib solution for infusion
-
Nottingham, United KingdomQuotient Sciences
Apr 15, 2022
Healthy Subjects Trial (Camizestrant, Itraconazole)
Completed
- Healthy Subjects
-
Harrow, United KingdomResearch Site
Jan 5, 2023
Healthy Subjects Trial in Phoenix (1.25 mg/kg BL-8040 + BL-8040-matching , 2 mg/kg BL-8040, BL-8040-matching )
Completed
- Healthy Subjects
- 1.25 mg/kg BL-8040 + BL-8040-matching placebo
- +3 more
-
Phoenix, ArizonaCelerion
Jan 1, 2023
Healthy Subjects, COVID-19 Pneumonia, Irritable Bowel Syndrome Trial in Hualien City (Jing Si Herbal Tea Liquid Packet, Jing Si
Recruiting
- Healthy Subjects
- +3 more
- Jing Si Herbal Tea Liquid Packet
- Jing Si Herbal Tea Liquid Packet Placebo
-
Hualien City, TaiwanHualien Tzu Chi Hospital
Jan 2, 2023